1. Organoid technology in cancer precision medicine.
- Author
-
Xia, Xinyi, Li, Fei, He, Juan, Aji, Rebiguli, and Gao, Dong
- Subjects
- *
INDIVIDUALIZED medicine , *DRUG resistance , *GENE expression , *TECHNOLOGY , *DISEASE progression - Abstract
Organoid technology has been remarkably improved over the last decade. Various organoids have been derived from different types of tissues and recapitulate their organ-specific gene expression signatures, particular tissue spatial structures and functions of their original tissue. The patient-derived organoids (PDOs) have been used to elucidate crucial scientific questions, including the relationships between genetic/epigenetic alterations and drug responses, cell plasticity during disease progressions, and mechanisms of drug resistances. With the great expectations, PDOs will be widely used to facilitate the personalized medical decisions, which have the potential to profoundly improve patient outcomes. In this review, we will discuss the developmental details, current achievements, applications and challenges of organoid technology in precision cancer medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF